I. El‐Najjar

Is the revised International staging system for myeloma valid in a real world population?

R. Benjamin, D. Ladon, M. Neat, 2018, British journal of haematology.

Added Value of Contrast‐Enhanced T1‐Weighted and Diffusion‐Weighted Sequences for Characterization of Incidental Findings on Whole Body Magnetic Resonance Imaging in Plasma‐Cell Disorders

V. Goh, R. Neji, H. Verma, 2018, Clinical lymphoma, myeloma & leukemia.

Added value of contrast-enhanced T1-weighted and diffusion-weighted sequences for characterisation of incidental findings on whole body magnetic resonance imaging (WBMRI) in plasma cell disorders.

R. Neji, H. Verma, O. Westerland, 2018 .

Added value of contrast-enhanced T1-weighted and diffusion-weighted sequences for characterisation of incidental findings on whole body magnetic resonance imaging (WBMRI) in plasma cell disorders.

R. Neji, H. Verma, O. Westerland, 2018 .

The role of FDG-PET and bone marrow examination in lymphoma staging.

S. Montoto, N. Avril, T. Barwick, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma

M. Gleeson, V. Goh, G. Cook, 2021, European Journal of Nuclear Medicine and Molecular Imaging.